Search

Bachem Holding AG

Closed

SectorHealthcare

49.7 2.05

Overview

Share price change

24h

Current

Min

47.94

Max

49.26

Key metrics

By Trading Economics

Income

36M

Sales

240M

P/E

Sector Avg

29.588

57.333

Dividend yield

1.8

Profit margin

15.046

Employees

2,207

EBITDA

55M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+42.49% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.80%

2.63%

Next Earnings

24 lip 2025

Market Stats

By TradingEconomics

Market Cap

3.5B

Previous open

47.65

Previous close

49.7

Bachem Holding AG Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

6 gru 2024, 11:00 UTC

Market Talk

Bachem Has Challenging Years Ahead With Strong Capital Expenditure -- Market Talk

Bachem Holding AG Forecast

Price Target

By TipRanks

42.49% upside

12 Months Forecast

Average 67.4 CHF  42.49%

High 78 CHF

Low 55 CHF

Based on 5 Wall Street analysts offering 12 month price targets forBachem Holding AG - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

5 ratings

2

Buy

3

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland.